Sanofi
SNYNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $5,496,000 | $5,400,000 | $8,371,000 | $6,223,000 |
| Dep. & Amort. | $3,586,000 | $4,792,000 | $3,150,000 | $3,351,000 |
| Deferred Tax | -$802,000 | -$970,000 | -$529,000 | -$356,000 |
| Stock-Based Comp. | $0 | $283,000 | $245,000 | $244,000 |
| Change in WC | -$615,000 | $764,000 | -$707,000 | $1,409,000 |
| Other Non-Cash | $1,416,000 | -$11,000 | -$4,000 | -$349,000 |
| Operating Cash Flow | $9,081,000 | $10,258,000 | $10,526,000 | $10,522,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,195,000 | -$3,253,000 | -$2,201,000 | -$2,043,000 |
| Net Acquisitions | -$2,524,000 | -$3,828,000 | -$858,000 | -$5,594,000 |
| Inv. Purchases | $0 | -$134,000 | -$488,000 | -$311,000 |
| Inv. Sales/Matur. | $0 | $42,000 | $1,488,000 | $718,000 |
| Other Inv. Act. | $1,312,000 | $973,000 | -$16,000 | -$68,000 |
| Investing Cash Flow | -$4,407,000 | -$6,200,000 | -$2,075,000 | -$7,298,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$894,000 | -$3,137,000 | -$1,245,000 | -$2,804,000 |
| Stock Issued | $187,000 | $195,000 | $188,000 | $186,000 |
| Stock Repurch. | -$302,000 | -$593,000 | -$497,000 | -$382,000 |
| Dividends Paid | -$4,704,000 | -$4,454,000 | -$4,168,000 | -$4,008,000 |
| Other Fin. Act. | -$50,000 | -$63,000 | -$99,000 | -$48,000 |
| Financing Cash Flow | -$5,763,000 | -$8,052,000 | -$5,821,000 | -$7,056,000 |
| Forex Effect | -$13,000 | -$32,000 | $8,000 | $15,000 |
| Net Chg. in Cash | -$1,269,000 | -$4,026,000 | $2,638,000 | -$3,817,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,710,000 | $12,736,000 | $10,098,000 | $13,915,000 |
| End Cash | $7,441,000 | $8,710,000 | $12,736,000 | $10,098,000 |
| Free Cash Flow | $5,886,000 | $8,639,000 | $8,325,000 | $8,479,000 |